These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24324573)

  • 21. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C; Chen CY; Evans D; Maskew M; Schulz D; Reyneke A; Kramvis A
    Int J Infect Dis; 2012 Apr; 16(4):e268-72. PubMed ID: 22305987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa.
    Samsunder N; Ngcapu S; Lewis L; Baxter C; Cawood C; Khanyile D; Kharsany ABM
    Int J Infect Dis; 2019 Aug; 85():150-157. PubMed ID: 31202910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection.
    Song BC; Cui XJ; Kim H
    Intervirology; 2005; 48(2-3):133-7. PubMed ID: 15812186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
    Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
    Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B: Who and when to treat?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2018 Feb; 38 Suppl 1():71-78. PubMed ID: 29427495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
    Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
    Salia E; Nartey YA; Djankpa FT; Pappoe F; Nuvor SV; Obiri-Yeboah D
    PLoS One; 2024; 19(6):e0305862. PubMed ID: 38924017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
    Iloeje UH; Yang HI; Chen CJ
    Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
    Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
    J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
    Su TH; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen CL; Chen PJ; Kao JH; Chen DS
    PLoS One; 2013; 8(2):e55916. PubMed ID: 23437072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
    Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
    Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C.
    Yan T; Li K; Li F; Su H; Mu J; Tong S; Patel M; Xia J; Wands JR; Wang H
    J Med Virol; 2011 Jun; 83(6):996-1004. PubMed ID: 21503912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
    Nien HC; Sheu JC; Kao JH; Chou HC; Su CW; Chen CH
    J Med Virol; 2011 Aug; 83(8):1326-31. PubMed ID: 21678436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
    Patel NH; Meier-Stephenson V; Genetu M; Damtie D; Abate E; Alemu S; Aleka Y; Van Marle G; Fonseca K; Coffin CS; Deressa T
    PLoS One; 2020; 15(11):e0242577. PubMed ID: 33211768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.